Hosted on MSN55m
BNP PARIBAS EXANE Upgrades Novo Nordisk A (NVO)Fintel reports that on January 5, 2025, BNP PARIBAS EXANE upgraded their outlook for Novo Nordisk A (NYSE:NVO) from Neutral ...
Scope of collaboration originally signed in 2023 will significantly expand to enable the discovery and development of up to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback